Plasmodium falciparum malaria continues to threaten human populations in the tropics and
travellers in endemic areas. Drug resistance of the parasite is a major problem in treating …

33 isolates, among 60 obtained between February and June 1996 from patients in
Lambaréné, Gabon, with Plasmodium falciparum malaria, were tested for susceptibility to …

Increasing resistance of Plasmodium falciparum to antimalarial drugs presents a major risk
factor for people living in endemic areas of tropical Africa. In Lambaréné, Gabon, regular …

We report on the first 2 years of operation of a new strategy for treatment for P. falciparum
malaria patients who were not cured by a standard course of chloroquine. Any such patient …

The sensitivity of Plasmodium falciparum to chloroquine, mefloquine, quinine, halofantrine,
and sulfadoxine/pyrimethamine has been investigated at Lambaréné, in the Gabonese rain …

During early 1990 5 Swedish expatriates living in Bissau developed falciparum malaria in
spite of taking standard chloroquine prophylaxis (combined with proguanil in 1 case). All the …

In vivo testing of the sensitivity of Plasmodium falciparum to chloroquine was carried out in
61 falciparum malaria patients with acute symptoms, in Eastern Sudan. In 26 patients (42%) …

Abstract Six Europeans and one African who had travelled to Gabon and/or Congo, were
admitted to hospitals in Paris and Rouen, France, with P. falciparum malaria. All had been …

This editorial summarizes a series of studies demonstrating the spread of Plasmodium
falciparum drug resistance in West Africa. From 1984 sensitivity to chloroquine, mefloquine …

The sensitivity of Plasmodium falciparum to chloroquine, mefloquine, quinine, quinidine,
halofantrine, artemisinin, and sulfadoxine/pyrimethamine was investigated in Lambarene …